I urge the FDA to schedule its review of Paxlovid and to make the timeline 3 weeks or less, as it did with the COVID vaccine.
1000 people are dying of COVID in the US every day. With an efficacy of 89%, Paxlovid could prevent many of these deaths. The earlier Paxlovid is approved, the more lives will be saved.
Thank you for your consideration.
I wasn’t sure what topic to put it under so I chose “Drug Industry—C0022.”
This seems like a good idea.
I submitted the following comment:
I wasn’t sure what topic to put it under so I chose “Drug Industry—C0022.”
Thank you for taking action!